Journalist Hunt

JournalistsPricingBlogs
LoginSign up

Keith T Flaherty - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Keith T Flaherty's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Keith T Flaherty

Keith T Flaherty

Verified

Editor-in-Chief, Clinical Cancer Research

Beats

Primary beats

ScienceHealth

Secondary beats

Artificial IntelligenceMedia AdvisingTechnology UpdatesGamingEthicsParty IdeasFramingEcotravelMental HealthMedia LanguageSocial Media PromotionWineInterpersonal CareBipoc-FocusedPeopleSmall BusinessesLifestyle Social MediaHealthcare SystemsIVFSpirits

Final Covers

African American genealogy and history HIV/AIDSCOVID-19 health disparities

Doesn’t Cover

What you may not find interesting.

Journalist Type

-

Seniority Positions

Chief

Industries

Medium Formats

-

Content

Total articles 54

  • A plain language summary of the 7-year update from part 1 of the COLUMBUS study: encorafenib and binimetinib for people with BRAF V600-mutant melanoma

    By Dirk Schadendorf, Reinhard Dummer, Keith T Flaherty, Caroline Robert

    Jan. 14, 2025

  • A Tale Of Two Pipelines

    By Dennis Chang, Keith T Flaherty, Uciane Scarlett

    Nov. 02, 2024

  • A plain language summary of the 7-year update from part 1 of the COLUMBUS study: encorafenib and binimetinib for people with BRAF V600-mutant melanoma

    By Dirk Schadendorf, Reinhard Dummer, Keith T Flaherty, Caroline Robert

    Jan. 14, 2025

As seen in

Taylor & Francis,Hemonc Today,Clinical Cancer Research,Nature,Cell Press,Cancer Discovery,Jama Dermatology,Nature Reviews Clinical Oncology,Healio,Annals Of Internal Medicine,The Lancet

Company Info

Clinical Cancer Research

Natick, Massachusetts, United States

+1 617-528-8715

Founded: